UMass Chan researchers achieve gene therapy milestone for potential Cockayne syndrome treatment
Researchers working with UMass Chan Medical School’s Translational Institute for Molecular Therapeutics announced progress in developing a vector to deliver gene replacement therapy in mice models with Cockayne syndrome, a rare and fatal neurodegenerative disease that largely affects children and young adults.
Read moreWelcome Video from Chancellor Collins
"Throughout the world and close to home we are UMass; dignified and determined; principled and purposeful; respected and relied upon!"
Stay connected
UMass Chan researchers achieve gene therapy milestone for potential Cockayne syndrome treatment
Researchers working with UMass Chan Medical School’s Translational Institute for Molecular Therapeutics announced progress in developing a vector to deliver gene replacement therapy in mice models with Cockayne syndrome, a rare and fatal neurodegenerative disease that largely affects children and young adults.
Read more